|
🐜
|
Epidemiology and costs of chronic obstructive pulmonary disease
12 auth.
K. Chapman,
D. Mannino,
J. Soriano,
P. Vermeire,
A. Buist,
M. Thun,
...
C. Connell,
A. Jemal,
Todd A. Lee,
M. Miravitlles,
S. Aldington,
R. Beasley
|
9 |
2006 |
9
🐜
|
|
🐜
|
Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study.
8 auth.
Victor Sobradillo Peña,
M. Miravitlles,
R. Gabriel,
Carlos A. Jiménez-Ruiz,
C. Villasante,
J. F. Masa,
...
J. Viejo,
L. Fernández-Fau
|
9 |
2000 |
9
🐜
|
|
🦁
|
Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities
8 auth.
M. Miravitlles,
J. Soriano,
F. García-Río,
Luis Muñoz,
E. Durán-Tauleria,
Guadalupe Sánchez,
...
V. Sobradillo,
J. Ancochea
|
9 |
2009 |
9
🦁
|
|
🐜
|
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
15 auth.
J. Wedzicha,
M. Miravitlles,
J. Hurst,
P. Calverley,
R. Albert,
A. Anzueto,
G. Criner,
A. Papi,
K. Rabe,
D. Rigau,
...
P. Śliwiński,
T. Tonia,
J. Vestbo,
K. Wilson,
J. Krishnan
|
9 |
2017 |
9
🐜
|
|
🐢
|
Chronic obstructive pulmonary disease
M. Decramer,
W. Janssens,
M. Miravitlles
|
8 |
2012 |
8
🐢
|
|
🐬
|
Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD
V. Brusasco,
R. Hodder,
M. Miravitlles,
L. Korducki,
L. Towse,
S. Kesten
|
8 |
2003 |
8
🐬
|
|
🐜
|
Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.
7 auth.
T. Welte,
M. Miravitlles,
P. Hernandez,
G. Eriksson,
S. Peterson,
T. Polanowski,
...
R. Kessler
|
8 |
2009 |
8
🐜
|
|
🐜
|
Symptom variability in patients with severe COPD: a pan-European cross-sectional study
8 auth.
R. Kessler,
M. Partridge,
M. Miravitlles,
M. Cazzola,
C. Vogelmeier,
D. Leynaud,
...
J. Ostinelli,
R. Kessler
|
8 |
2010 |
8
🐜
|
|
🦁
|
Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.
M. Miravitlles,
C. Espinosa,
Enrique Fernández-Laso,
José Alberto Martos,
J. Maldonado,
M. Gallego
|
8 |
1999 |
8
🦁
|
|
🐜
|
Determinants of underdiagnosis of COPD in national and international surveys.
18 auth.
B. Lamprecht,
J. Soriano,
M. Studnicka,
B. Kaiser,
L. Vanfleteren,
L. Gnatiuc,
P. Burney,
M. Miravitlles,
F. García-Río,
K. Akbari,
...
J. Ancochea,
A. Menezes,
R. Perez-Padilla,
M. Montes de Oca,
C. Torres-Duque,
Andrés Caballero,
M. González-García,
S. Buist
|
8 |
2015 |
8
🐜
|
|
🦁
|
Understanding the impact of symptoms on the burden of COPD
M. Miravitlles,
A. Ribera
|
8 |
2017 |
8
🦁
|
|
🦁
|
Factors Associated with Increased Risk of Exacerbation and Hospital Admission in a Cohort of Ambulatory COPD Patients: A Multiple Logistic Regression Analysis
M. Miravitlles,
T. Guerrero,
C. Mayordomo,
L. Sanchez-Agudo,
F. Nicolau,
J. L. Segú
|
8 |
2000 |
8
🦁
|
